Evidence map›Paper›PMID 39301469›Full record

ArticleJournal of psoriasis and psoriatic arthritis2023

Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings.

Carly Grant, Lourdes Perez-Chada, Rebecca H Haberman, Daniel Webster, Oliver FitzGerald, Christopher Ritchlin, Vinod Chandran, Cheryl F Rosen, Brittany Weber, Michael Garshick and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of psoriasis and psoriatic arthritis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Carly GrantDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lourdes Perez-ChadaDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rebecca H HabermanDivision of Rheumatology, Department of Medicine, New York University Langone Health, New York, NY, USA.
Daniel WebsterSage Bionetworks, Seattle, WA, USA.
Oliver FitzGeraldConway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
Christopher RitchlinAllergy, Immunology, and Rheumatology Division, University of Rochester Medical School, Rochester, NY, USA.
Vinod ChandranDivision of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Cheryl F RosenDivision of Dermatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
Brittany WeberDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Michael GarshickCenter for the Prevention of Cardiovascular Disease, Department of Medicine, NYU Langone Health, New York, NY, USA.
Lihi EderWomen's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
Soumya M ReddyDivision of Rheumatology, Department of Medicine, New York University Langone Health, New York, NY, USA.
Alexis OgdieDivision of Rheumatology, Department of Medicine, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jose U ScherDivision of Rheumatology, Department of Medicine, New York University Langone Health, New York, NY, USA.
Joseph F MerolaDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Funding

Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasisK23HL159276 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI WEBER, BRITTANY NICOLE · 2021 to 2025
$962k
NHLBI NIH HHS K23 HL159276
6 · The paper itself

Abstract

The Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) is a nonprofit organization whose mission is to optimize the clinical care of patients with psoriatic disease through multidisciplinary collaboration models. The PPACMAN 2021 Annual Meeting was held virtually on December 11, 2021. In all, 50 stakeholders participated in the meeting including dermatologists, rheumatologists, cardiologists, clinical researchers, patient advocacy representatives, and industry representatives. During the opening session of the meeting, presenters provided an update of several research projects dedicated to predicting and preventing psoriatic arthritis (PsA) such as the Psorcast, PAMPA, HIPPOCRATES, and the ELLIPSS studies. The second session centered around novel approaches to deliver multidisciplinary care in psoriatic disease. PPACMAN leadership introduced its wellness program and invited speakers to discuss new advances in cardiovascular disease, sleep disturbance, mental health problems, and dietary interventions in psoriatic disease. The final session of the meeting focused on how to improve patient engagement in their disease and care.

Indexed as

combined clinicsconsensus terminologypsoriasispsoriatic arthritissystems-based practices

Identifiers

PMID39301469
PMCPMC11361532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.